Technical Analysis for CDXC - ChromaDex Corporation

Grade Last Price % Change Price Change
A 5.86 67.91% 2.37
CDXC closed up 67.91 percent on Friday, November 1, 2024, on 37.11 times normal volume. The bulls were able to push the stock to a new 52-week high.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
New 52 Week High Strength 0.00%
Parabolic Rise Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Earnings Movers Other 0.00%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 18 hours ago
Gapped Up (Full) about 21 hours ago
Rose Above Previous Day's High about 21 hours ago
New 52 Week High about 21 hours ago
Rose Above Upper Bollinger Band about 21 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ChromaDex Corporation Description

ChromaDex Corporation, a natural products company, through its subsidiaries, discovers, acquires, develops, and commercializes patented and proprietary ingredient technologies. The company supplies bulk raw materials for use in dietary supplements, food, beverages, and cosmetic products; reference standards, materials, and kits to conduct quality control of raw materials and consumer products; and fine chemicals and phytochemicals for research and new product development applications. It also provides a range of contract services, including routine contract analysis for the production of dietary supplements, cosmetics, foods, and other natural products, as well as elaborate contract research for clients in these industries; and consulting services in the areas of regulatory support, new ingredient or product development, risk management, and litigation support, as well as product regulatory approval and scientific advisory services. The company's products and services in development include Nicotinamide riboside, a vitamin found naturally in milk for enhancing cardiovascular health, glucose levels, cognitive function, and anti-aging effects; Pterostilbene and caffeine co-crystal that are ingredients for the formulation of energy products; and Anthocyanins for application in dietary supplement, sports nutrition, food and beverage, and skin care products. In addition, it is developing quality verification seal program, phytochemical libraries, plant extracts libraries, and databases for cross-referencing phytochemicals. The company markets and sells its products directly in the United States and Canada; and through distributors in Europe, South America, China, Korea, India, Japan, Australia, New Zealand, Indonesia, Malaysia, Singapore, Thailand, and Mexico. ChromaDex Corporation is headquartered in Irvine, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Chemical Consumer Products Beverage Risk Management Vitamins Skin Care Dietary Supplement Glucose Milk Energy Products Nutrition Fine Chemical Quality Control Skin Care Products Contract Services Sports Nutrition Cosmetic Products Natural Products New Product Development

Is CDXC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.98
52 Week Low 1.32
Average Volume 1,018,803
200-Day Moving Average 2.97
50-Day Moving Average 3.53
20-Day Moving Average 3.58
10-Day Moving Average 3.75
Average True Range 0.33
RSI (14) 84.89
ADX 21.68
+DI 61.20
-DI 6.25
Chandelier Exit (Long, 3 ATRs) 4.98
Chandelier Exit (Short, 3 ATRs) 4.18
Upper Bollinger Bands 4.65
Lower Bollinger Band 2.51
Percent B (%b) 1.57
BandWidth 59.58
MACD Line 0.21
MACD Signal Line 0.06
MACD Histogram 0.1542
Fundamentals Value
Market Cap 440.23 Million
Num Shares 75.1 Million
EPS -0.09
Price-to-Earnings (P/E) Ratio -65.11
Price-to-Sales 1.38
Price-to-Book 4.21
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.09
Resistance 3 (R3) 8.77 7.37 8.55
Resistance 2 (R2) 7.37 6.55 7.53 8.37
Resistance 1 (R1) 6.62 6.04 7.00 6.94 8.19
Pivot Point 5.22 5.22 5.41 5.38 5.22
Support 1 (S1) 4.47 4.40 4.85 4.79 3.53
Support 2 (S2) 3.07 3.89 3.23 3.35
Support 3 (S3) 2.32 3.07 3.17
Support 4 (S4) 2.64